The Protective Effects of Silymarin on the Reproductive Toxicity: A Comprehensive Review

Tita Hariyanti1, Ria Margiana2,3,4,5, Moaed Emran Al-Gazally6

  • 1Department of Public Health, Faculty of Medicine, Universitas Brawijaya, Malang, East Java, Indonesia.

Insights

Silymarin, a medicinal herb extract, shows promise in protecting the reproductive system from damage caused by chemotherapy and toxins. Its antioxidant and anti-inflammatory properties offer a safe therapeutic approach for reproductive health.

Area of Science:

  • Reproductive Toxicology
  • Pharmacology
  • Herbal Medicine

Background:

  • The reproductive system is susceptible to various toxins, including chemotherapy drugs, radiation, and heavy metals.
  • These harmful stimuli can cause oxidative damage, apoptosis, and inflammation, leading to adverse reproductive effects.
  • Medicinal plants, like silymarin from Silybum marianum, are recognized for their therapeutic potential in managing health conditions.

Conclusions:

  • Silymarin is a safe and effective agent for preventing and treating reproductive toxicity.
  • Understanding its molecular mechanisms provides a basis for therapeutic strategies.
  • Further research into advanced delivery systems can optimize silymarin's role in reproductive medicine.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...